DiaSorin SpA
MIL:DIA

Watchlist Manager
DiaSorin SpA Logo
DiaSorin SpA
MIL:DIA
Watchlist
Price: 100.15 EUR -0.1% Market Closed
Market Cap: 5.6B EUR
Have any thoughts about
DiaSorin SpA?
Write Note

Operating Margin
DiaSorin SpA

21.3%
Current
26%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
21.3%
=
Operating Profit
309m
/
Revenue
1.4B

Operating Margin Across Competitors

Country IT
Market Cap 5.3B EUR
Operating Margin
21%
Country US
Market Cap 198.3B USD
Operating Margin
17%
Country US
Market Cap 189.1B USD
Operating Margin
26%
Country US
Market Cap 140.4B USD
Operating Margin
22%
Country US
Market Cap 132.3B USD
Operating Margin
18%
Country IE
Market Cap 104.2B USD
Operating Margin
19%
Country US
Market Cap 65.2B USD
Operating Margin
14%
Country DE
Market Cap 58.1B EUR
Operating Margin
12%
Country US
Market Cap 44.1B USD
Operating Margin
28%
Country CN
Market Cap 309.1B CNY
Operating Margin
36%
Country US
Market Cap 36.2B USD
Operating Margin
13%
No Stocks Found

DiaSorin SpA
Glance View

Market Cap
5.3B EUR
Industry
Health Care

In the heart of the global healthcare landscape, DiaSorin SpA stands as a testament to innovation and precision in the field of biotechnology. Founded in 1968 in Italy, the company built its reputation on developing and producing diagnostic tests that help identify and monitor diseases. With a primary focus on immunodiagnostic and molecular diagnostic products, DiaSorin excels in creating high-quality, reliable solutions that clinicians and labs around the world depend on. Their product portfolio ranges widely, covering infectious diseases, oncology, endocrinology, and more. By leveraging cutting-edge research and development processes, DiaSorin not only prioritizes accuracy and efficiency in its testing solutions but also adapts to the ever-evolving demands of the medical world, cementing its role as a leader in diagnostic innovation. From a business perspective, DiaSorin's revenue streams are deeply intertwined with its prowess in developing proprietary testing technologies, including both instruments and consumables. The company operates with a dual-channel business model where it sells diagnostic machines to laboratories, hospitals, and clinics while simultaneously providing the reagents and kits necessary for these machines' continuous operation. This approach ensures not only a sale of sophisticated equipment but also a recurring revenue stream from the consumables needed for diagnostics. With a strategic emphasis on research and partnerships, DiaSorin has expanded its reach globally, ensuring its products meet diverse regional healthcare requirements. Through a combination of robust product offerings and strategic global expansion, DiaSorin continues to thrive and maintain its position as a pivotal contributor to the field of diagnostic medicine.

DIA Intrinsic Value
94.73 EUR
Overvaluation 5%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
21.3%
=
Operating Profit
309m
/
Revenue
1.4B
What is the Operating Margin of DiaSorin SpA?

Based on DiaSorin SpA's most recent financial statements, the company has Operating Margin of 21.3%.